MedTrace Logo

Macrolane Retrospective Study

NCT01223963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

This is a retrospective, multicenter chart review of medical records on the use of Macrolane for female breast enhancement.

The primary objective is to evaluate the safety profile of Macrolane Volume Restoration Factor 20 and Macrolane Volume Restoration Factor 30 when used for female breast enhancement in clinical practice.

Conditions

  • Women Who Have Had Breast Enhancement With Macrolane VRF

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Per Hedén, Md PhD · Akademikliniken

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01223963 on ClinicalTrials.gov